References
- AlberghinaLChiaradonnaFVanoniMSystems biology and the molecular circuits of cancerChembiochem20045101322133315457529
- FearonERHuman cancer syndromes: clues to the origin and nature of cancerScience19972785340104310509353177
- VogelsteinBKinzlerKWCancer genes and the pathways they controlNat Med200410878979915286780
- SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
- American Cancer Society IncBreast Cancer Facts & Figures 2015–2016AtlantaAmerican Cancer Society Inc2015
- OlszewskiUHamiltonGA better platinum-based anticancer drug yet to come?Anticancer Agents Med Chem201010429330120187870
- DiyabalanageHVGrandaMLHookerJMCombination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancerCancer Lett201332911823032720
- ZhangXFYanQShenWGurunathanSTrichostatin A enhances the apoptotic potential of palladium nanoparticles in human cervical cancer cellsInt J Mol Sci2016178 pii:E1354
- ChaoMWLaiMJLiouJPThe synergic effect of vincristine and vorinostat in leukemia in vitro and in vivoJ Hematol Oncol201588226156322
- ThurnKThomasSRahaPQureshiIMunsterPNInhibition of class I histone deacetylases attenuates anthracycline induced activation of the ATM pathwayCancer Res2011718 Suppl Abstract 2614
- PetruccelliLADupere-RicherDPetterssonFRetrouveyHSkoulikasSMillerWHJrVorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cellsPLoS One201166e2098721695163
- OkadaMLeeLMaekawaREpigenetic changes of the Cyp11a1 promoter region in granulosa cells undergoing luteinization during ovulation in female ratsEndocrinology201615793344335427428926
- RosikLNiegischGFischerUJungMSchulzWAHoffmannMJLimited efficacy of specific HDAC6 inhibition in urothelial cancer cellsCancer Biol Ther201415674275724618845
- MishraSKMandalMMazumdarAKumarRDynamic chromatin remodeling on the HER2 promoter in human breast cancer cellsFEBS Lett20015071889411682064
- AriffinJKdas GuptaKKapetanovicRHistone deacetylase inhibitors promote mitochondrial reactive oxygen species production and bacterial clearance by human macrophagesAntimicrob Agents Chemother20156031521152926711769
- FalkenbergKJJohnstoneRWHistone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersNat Rev Drug Discov201413967369125131830
- LiZZhuWGTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsInt J Biol Sci201410775777025013383
- ZhangJZhongQHistone deacetylase inhibitors and cell deathCell Mol Life Sci201471203885390124898083
- DavisMEChenZShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
- GurunathanSHanJWEppakayalaVJeyarajMKimJHCytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cellsBiomed Res Int2013201353579623936814
- GurunathanSKimEHanJWParkJHKimJHGreen chemistry approach for synthesis of effective anticancer palladium nanoparticlesMolecules20152012224762249826694334
- WuXJZhouLZSuYDongCMAn autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapyJ Mater Chem B201641221422152
- CooksonJThe Preparation of Palladium NanoparticlesPlatin Met Rev20125628398
- AstrucDPalladium nanoparticles as efficient green homogeneous and heterogeneous carbon-carbon coupling precatalysts: a unifying viewInorg Chem20074661884189417348719
- SemaginaNRenkenAKiwi-MinskerLPalladium nanoparticle size effect in 1-hexyne selective hydrogenationJ Phys Chem C2007111371393313937
- DimitratosNPortaFPratiLVillaASynergetic effect of platinum or palladium on gold catalyst in the selective oxidation of D-sorbitolCatal Lett2005993–4181185
- BellerMFischerHKühleinKReisingerCPHerrmannWAFirst palladium-catalyzed Heck reactions with efficient colloidal catalyst systemsJ Organomet Chem19965201–2257259
- CheongSSWattJDTilleyRDShape control of platinum and palladium nanoparticles for catalysisNanoscale20102102045205320694209
- AnhTDAhnMYKimSAYoonJHAhnSGThe histone deacetylase inhibitor, trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cellsOncol Rep201227245546021993600
- GurunathanSJeongJKHanJWZhangXFParkJHKimJHMultidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cellsNanoscale Res Lett2015103525852332
- GurunathanSRamanJMalekNAJohnPAVikineswarySGreen synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cellsInt J Nanomed2013843994413
- MahdiehMZolanvariAAzimeeASMahdiehMGreen biosynthesis of silver nanoparticles by Spirulina platensisSci Iran2012193926929
- PatelVBertholdDPuranikPGantarMScreening of cyanobacteria and microalgae for their ability to synthesize silver nanoparticles with antibacterial activityBiotechnol Rep20155112119
- BekasovaODBrekhovskikhAARevinaAADubinchukVTPreparation and optical properties of silver nanoparticles in R-phycoerythrin, a protein matrixInorg Mater2008448835841
- ShenyDSPhilipDMathewJRapid green synthesis of palladium nanoparticles using the dried leaf of Anacardium occidentaleSpectrochim Acta A Mol Biomol Spectrosc201291353822349890
- KhanMKhanMKuniyilMBiogenic synthesis of palladium nanoparticles using Pulicaria glutinosa extract and their catalytic activity towards the Suzuki coupling reactionDalton Trans201443249026903124619034
- NadagoudaMNVarmaRSGreen synthesis of silver and palladium nanoparticles at room temperature using coffee and tea extractGreen Chem2008108859862
- XuWSParmigianiRBMarksPAHistone deacetylase inhibitors: molecular mechanisms of actionOncogene200726375541555217694093
- ChangJVargheseDSGillamMCDifferential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptideBr J Cancer2012106111612522158273
- YanGEllerMSElmCSelective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cellsJ Invest Dermatol2013133102444245223698071
- ChanSTYangNCHuangCSLiaoJWYehSLQuercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivoPLoS One201381e5425523342112
- ZhangYWZhengYWangJZIntegrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancerEpigenetics20149689690924699858
- KaliszczakMTrousilSAbergOPerumalMNguyenQDAboagyeEOA novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growthBr J Cancer2013108234235023322205
- SinghTPrasadRKatiyarSKInhibition of class I histone deacetylases in non-small cell lung cancer cells by honokiol leads to suppression of cancer cell proliferation and induction of cell death in vitro and in vivo modelsEpigenetics201381546523221619
- ZhangXJiangSJShangBJiangHJEffects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell lineThorac Cancer20156220220826273359
- NetalaVRBethuMSPushpalathaBBiogenesis of silver nanoparticles using endophytic fungus Pestalotiopsis microspora and evaluation of their antioxidant and anticancer activitiesInt J Nanomedicine2016115683569627826190
- NaoraHNishidaTShindoYAdachiMNaoraHConstitutively enhanced nbl expression is associated with the induction of internucleosomal DNA cleavage by actinomycin DBiochem Biophys Res Commun199622412582648694823
- NikiTRomboutsKDe BleserPA histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary cultureHepatology199929385886710051490
- CarewJSGilesFJNawrockiSTHistone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapyCancer Lett2008269171718462867
- RosatoRRGrantSHistone deacetylase inhibitors: insights into mechanisms of lethalityExpert Opin Ther Targets20059480982416083344
- RahmaniMReeseEDaiYBauerCPayneSGCoadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen speciesCancer Res2005652422243215781658
- LouisMRosatoRRBraultLThe histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stressInt J Oncol20042561701171115547708
- RosatoRRAlmenaraJAGrantSThe histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21 (CIP1/WAF1)Cancer Res200363133637364512839953
- RosatoRRAlmenaraJAMaggioSCRole of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactionsMolecular Cancer Ther200871032853297
- RuefliAAAusserlechnerMJBernhardDThe histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen speciesP Natl Acad Sci U S A200198191083310838
- KalyanaramanBTeaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanismsRedox Biol20131124425724024158
- UngerstedtJSSowaYXuWSRole of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitorsProc Natl Acad Sci U S A2005102367367815637150
- HoEKarimi GalougahiKLiuCCBhindiRFigtreeGABiological markers of oxidative stress: applications to cardiovascular research and practiceRedox Biol2013148349124251116
- YouBRParkWHSuberoyl bishydroxamic acid-induced apoptosis in HeLa cells via ROS-independent, GSH-dependent mannerMol Biol Rep20134053807381623269626
- BrechbuhlHMKachadourianRMinEChanDDayBJChrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathioneToxicol Appl Pharmacol201225811921856323
- FathMAAhmadIMSmithCJSpenceJSpitzDREnhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolismClin Cancer Res201117196206621721844013
- SchnelldorferTGansaugeSGansaugeFSchlosserSBegerHGNusslerAKGlutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cellsCancer20008971440144711013356
- MiriyalaSSpasojevicITovmasyanAManganese superoxide dismutase, MnSOD and its mimicsBiochim Biophys Acta20121822579481422198225
- SenaLAChandelNSPhysiological roles of mitochondrial reactive oxygen speciesMol Cell201248215816723102266
- PeartMJTaintonKMRuefliAANovel mechanisms of apoptosis induced by histone deacetylase inhibitorsCancer Res200363154460447112907619
- JiangSJDowdySCMengXWHistone deacetylase inhibitors induce apoptosis in both type I and type II endometrial cancer cellsGynecol Oncol2007105249350017303224
- SunBBFuLNWangYQSilencing of JMJD2B induces cell apoptosis via mitochondria-mediated and death receptor-mediated pathway activation in colorectal cancerJ Dig Dis201415949150024957706
- ZhouWQFengXYHanHGuoSCWangGDSynergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cellsSci Rep201662800427292433
- OkadaKHakataSTerashimaJGamouTHabanoWOzawaSCombination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cellsOncol Rep20163641875188527509880
- WolfBBGreenDRSuicidal tendencies: apoptotic cell death by caspase family proteinasesJ Biol Chem199927429200492005210400609
- WolfBBSchulerMEcheverriFGreenDRCaspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivationJ Biol Chem199927443306513065610521451
- LeeEFurukuboTMiyabeTYamauchiAKariyaKInvolvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosisFEBS Lett19963952–31831878898091
- BoldenJEPeartMJJohnstoneRWAnticancer activities of histone deacetylase inhibitorsNat Rev Drug Discov20065976978416955068
- GlozakMASenguptaNZhangXHSetoEAcetylation and deacetylation of non-histone proteinsGene2005363152316289629
- MarksPADokmanovicMHistone deacetylase inhibitors: discovery and development as anticancer agentsExpert Opin Investig Drugs2005141214971511
- MinucciSPelicciPGHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNat Rev Cancer200661385116397526
- ZhaoYTanJZhuangLJiangXLiuETYuQInhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein BimProc Natl Acad Sci U S A200510244160901609516243973
- ZhangXDGillespieSKBorrowJMHerseyPThe histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cellsMol Cancer Ther20043442543515078986
- XuWNgoLPerezGDokmanovicMMarksPAIntrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitorProc Natl Acad Sci U S A200610342155401554517030815
- RosatoRRMaggioSCAlmenaraJAThe histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramideMol Pharmacol200669121622516189296
- JiangXJWangXDCytochrome C-mediated apoptosisAnnu Rev Biochem2004738710615189137
- YangXMShiZLZhangNSuberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cellsCancer Cell Int20141410725729327
- HanMHParkCKwonTKThe histone deacetylase inhibitor trichostatin A sensitizes human renal carcinoma cells to TRAIL-induced apoptosis through down-regulation of c-FLIPLBiomol Ther (Seoul)2015231313825593641